share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 26 22:28
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/26/2024, with an aggregate market value of $1,075,521.60. The shares were acquired on 02/17/2024 as part of a restricted stock vesting and were compensation from the issuer. This planned sale follows a recent transaction history where Bozic sold a total of 4,560 shares over the past three months, generating total gross proceeds of $2,105,716.80.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/26/2024, with an aggregate market value of $1,075,521.60. The shares were acquired on 02/17/2024 as part of a restricted stock vesting and were compensation from the issuer. This planned sale follows a recent transaction history where Bozic sold a total of 4,560 shares over the past three months, generating total gross proceeds of $2,105,716.80.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.